Effects of luteinizing hormone, follicle-stimulating hormone, and epidermal growth factor on expression and kinase activity of cyclin-dependent kinase 5 in Leydig TM3 and Sertoli TM4 cell lines - PubMed (original) (raw)
. 2000 May-Jun;21(3):392-402.
Affiliations
- PMID: 10819446
Free article
Effects of luteinizing hormone, follicle-stimulating hormone, and epidermal growth factor on expression and kinase activity of cyclin-dependent kinase 5 in Leydig TM3 and Sertoli TM4 cell lines
F R Musa et al. J Androl. 2000 May-Jun.
Free article
Abstract
We examined the effects of luteinizing hormone (LH), follicle-stimulating hormone (FSH), and epidermal growth factor (EGF) on the expression and kinase activity of cyclin-dependent kinase 5 (Cdk5) in Leydig TM3 and Sertoli TM4 cell lines. Hormonal regulation of the expression and activity of Cdk5 by using normal and hypophysectomized rat testes was also investigated to elucidate its role. Cdk5 levels and kinase activity were significantly elevated in TM3 cells that were grown in the presence of 7.5% serum, EGF, or LH and were associated with an increase in testosterone production compared with controls. These increases were accompanied by an increase in proliferation of TM3 cells after treatment with serum or EGF but not with LH suggest that Cdk5 may be involved in cellular differentiation that is induced with LH treatment. In contrast, the presence of neither serum, EGF, nor FSH had a significant effect on Cdk5 activity levels in the Sertoli TM4 cell line, and there was no correlation with proliferative activity or transferrin levels. A significant decrease in Cdk5 expression and activity were noted in rat testis after hypophysectomy compared with normal rat testis and is associated with a simultaneous decrease in testosterone and transferrin levels. Immunohistochemical analysis revealed that Cdk5 was strongly expressed in the nuclei and cytoplasm of Leydig cells, Sertoli cells, spermatogonia, and peritubular cells of normal adult rat testis. After hypophysectomy, the pattern of Cdk5 staining differed markedly from that in normal rat testis and a profound reduction in staining of Cdk5 was observed in each tubule. Our results suggest that LH and EGF influence and modulate Cdk5 expression and activity in Leydig TM3 cells and may, conceivably, be involved in signal transduction cascades that are initiated by hormones or growth factors. Cdk5 in Sertoli TM4 cells is likely to possess some constitutive functions that are not affected by the cells' proliferation state. Moreover, Cdk5 is probably involved in the constitutive and hormonally stimulated activities of the rat testis, in addition to its involvement in cell proliferation.
Similar articles
- Expression of cyclin-dependent kinase 5 and associated cyclins in Leydig and Sertoli cells of the testis.
Musa FR, Tokuda M, Kuwata Y, Ogawa T, Tomizawa K, Konishi R, Takenaka I, Hatase O. Musa FR, et al. J Androl. 1998 Nov-Dec;19(6):657-66. J Androl. 1998. PMID: 9876017 - Pituitary control of proliferation and differentiation of Leydig cells and their putative precursors in immature hypophysectomized rat testis.
Dombrowicz D, Sente B, Reiter E, Closset J, Hennen G. Dombrowicz D, et al. J Androl. 1996 Nov-Dec;17(6):639-50. J Androl. 1996. PMID: 9016394 - Stimulation of adult rat Leydig cell aromatase activity by a Sertoli cell factor.
Carreau S, Papadopoulos V, Drosdowsky MA. Carreau S, et al. Endocrinology. 1988 Mar;122(3):1103-9. doi: 10.1210/endo-122-3-1103. Endocrinology. 1988. PMID: 2830095 - Hormones and hormonal target cells in the testis.
Hansson V, Djoseland O, Torgersen O, Ritzen EM, French FS, Nayfeh SN. Hansson V, et al. Andrologia. 1976;8(3):195-202. doi: 10.1111/j.1439-0272.1976.tb02135.x. Andrologia. 1976. PMID: 187086 Review. - Modulation of steroidogenic activities in testis Leydig cells.
Rommerts FF, Brinkman AO. Rommerts FF, et al. Mol Cell Endocrinol. 1981 Jan;21(1):15-28. doi: 10.1016/0303-7207(81)90026-5. Mol Cell Endocrinol. 1981. PMID: 6259000 Review.
Cited by
- Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.
Choi JH, Banks AS, Estall JL, Kajimura S, Boström P, Laznik D, Ruas JL, Chalmers MJ, Kamenecka TM, Blüher M, Griffin PR, Spiegelman BM. Choi JH, et al. Nature. 2010 Jul 22;466(7305):451-6. doi: 10.1038/nature09291. Nature. 2010. PMID: 20651683 Free PMC article. - Regulation of the steroidogenic acute regulatory protein gene expression: present and future perspectives.
Manna PR, Dyson MT, Stocco DM. Manna PR, et al. Mol Hum Reprod. 2009 Jun;15(6):321-33. doi: 10.1093/molehr/gap025. Epub 2009 Mar 25. Mol Hum Reprod. 2009. PMID: 19321517 Free PMC article. Review. - Future Aspects of CDK5 in Prostate Cancer: From Pathogenesis to Therapeutic Implications.
Oner M, Lin E, Chen MC, Hsu FN, Shazzad Hossain Prince GM, Chiu KY, Teng CJ, Yang TY, Wang HY, Yue CH, Yu CH, Lai CH, Hsieh JT, Lin H. Oner M, et al. Int J Mol Sci. 2019 Aug 9;20(16):3881. doi: 10.3390/ijms20163881. Int J Mol Sci. 2019. PMID: 31395805 Free PMC article. Review. - The gonadotropin connection in Alzheimer's disease.
Meethal SV, Smith MA, Bowen RL, Atwood CS. Meethal SV, et al. Endocrine. 2005 Apr;26(3):317-26. doi: 10.1385/ENDO:26:3:317. Endocrine. 2005. PMID: 16034187 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources